![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Hepatitis |
Free Subscription
1 Am J Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Hepatitis is free of charge.
Patients With Compensated Hepatitis B Virus-Related Cirrhosis and Low-Level
Viremia: Treat or Not to Treat?
Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002224.
PubMed
Abstract available
A novel nomogram to predict 90-day mortality in patients with hepatitis B
virus-related acute-on-chronic liver failure: a single-center retrospective
study.
BMC Gastroenterol. 2023;23:86.
PubMed
Abstract available
First hepatitis D medicine is given restricted approval in Scotland after US
rejection.
BMJ. 2023;380:p660.
PubMed
Three double-dose reinforced hepatitis B revaccination scheme for patients with
cirrhosis unresponsive to the standard regimen: an open-label randomised clinical
trial.
Gut. 2023 Mar 24:gutjnl-2022-328222. doi: 10.1136/gutjnl-2022-328222.
PubMed
Abstract available
Global burden of liver cancer in males and females: Changing etiological basis
and the growing contribution of NASH.
Hepatology. 2023;77:1150-1163.
PubMed
Abstract available
Attacking the Public Health Crisis of Hepatocellular Carcinoma at its Roots.
Hepatology. 2022 Aug 21. doi: 10.1002/hep.32741.
PubMed
Risk of parenterally transmitted hepatitis following exposure to invasive
procedures in Italy: SEIEVA surveillance 2000-2021.
J Hepatol. 2023 Mar 17:S0168-8278(23)00177-0. doi: 10.1016/j.jhep.2023.
PubMed
Abstract available
Discovery of a first-in-class orally available HBV cccDNA inhibitor.
J Hepatol. 2023;78:742-753.
PubMed
Abstract available
Targeting proteostasis of the HEV replicase to combat infection in preclinical
models.
J Hepatol. 2023;78:704-716.
PubMed
Abstract available
Nationwide hepatitis C serosurvey and progress towards HCV elimination in the
country of Georgia, 2021.
J Infect Dis. 2023 Mar 18:jiad064. doi: 10.1093.
PubMed
Abstract available
Humoral responses after primary and booster SARS-CoV-2 inactivated vaccination in
patients with chronic hepatitis B virus infection: a longitudinal observational
study.
J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28695.
PubMed
Abstract available
New Approaches to Chronic Hepatitis B. Reply.
N Engl J Med. 2023;388:1148-1149.
PubMed
New Approaches to Chronic Hepatitis B.
N Engl J Med. 2023;388:1148.
PubMed
Efficacy and Safety of Bepirovirsen in Hepatitis B. Reply.
N Engl J Med. 2023;388:1147-1148.
PubMed
Efficacy and Safety of Bepirovirsen in Hepatitis B.
N Engl J Med. 2023;388:1146-1147.
PubMed
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by